RELATING TO INSURANCE.
Summary
Beginning 1/1/2025, requires health insurers, mutual benefit societies, health maintenance organizations, and health plans under the State's Medicaid managed care program to provide coverage for biomarker testing. Effective 7/1/3000. (HD1)
Bill status
in committee
3 of 5 stages cleared
Introduction
Jan 2024
Committee Review
Feb 2024
House Passage
Feb 2024
Senate Passage
Governor
Introduced Jan 22, 2024
Last action Feb 8, 2024
Floor votes · House Feb 8, 2024
How they voted
47–0
Passed · 4 other
Total votes 51
Feb 8, 2024
D
Democratic44
93% Yea
R
Republican7
85% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
8
Key actions
2
Committee
3
Feb 8, 2024
Committee
Reported from HLT (Stand. Com. Rep. No. 198-24) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
lower
Feb 8, 2024
House · Passed
House Vote: pass (47-0-4)
house
Jan 31, 2024
Lower · Passed
The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Belatti, Takenouchi, Amato, Ilagan, Kobayashi, Marten, Nishimoto, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.
lower
Jan 26, 2024
Committee
Referred to HLT, CPC, FIN, referral sheet 3
lower
Jan 24, 2024
Introduced
Introduced and Pass First Reading.
lower
Jan 22, 2024
Introduced
Pending introduction.
lower
8 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2223
Scope: HI
Hi! I can help you understand HB 2223. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline